1/23
Cancer Research
Developing a tiny anticancer weapon
Penn Medicine researchers have developed tumor-homing nanosized particles that trigger cancer cell self-destruction in preclinical tests.
Discovery links cellular structures to kidney cancer treatment outcomes
New research from Penn Medicine finds patterns in cells of tumors may guide personalized therapies for clear cell renal cell carcinoma.
New tool puts reproductive risk for BRCA carriers into perspective
A team at Penn Medicine has created a resource to help inform reproductive counseling for cancer gene mutation carriers.
Generic platinum chemotherapy shortages did not increase deaths
A national data analysis finds that short-term mortality was not impacted by the shortage for patients with advanced cancers.
Brain tumor organoids accurately model patient response to CAR T cell therapy
Lab-grown tumors respond to cell therapy the same as tumors in the patients’ brains, according to researchers at Penn Medicine.
Keto diet metabolite may power up CAR T cells to kill cancer
Laboratory studies reveal a potentially low-tech intervention to improve personalized cell therapy.
Easing patient fears of radiation treatment, via virtual reality
Before their first dose of radiation, cancer patients can shadow another patient’s treatment and get a private behind-the-scenes tour with the team members via virtual reality.
White House names Abramson Cancer Center neuro-oncologist a Cancer Moonshot Scholar
Richard E. Phillips, chief of the division of Neuro-Oncology and an assistant professor of neurology, is among 11 scholars included in this year’s cohort, who will support cancer research and innovation across the country.
Combo immunotherapy produces distinct waves of cancer-fighting T cells
Researchers from Penn’s Abramson Cancer Center have found that a novel tool that tracks immune health over time has revealed new insights on immune cell activation.
Understanding the cellular mechanisms driving solid tumors’ robust defense system
Researchers from Penn have identified a “forcefield-like” defense system in solid tumors and the genetic elements that can switch it off.
In the News
Keto diet supplement could boost a cancer treatment's effectiveness
A study by Perelman School of Medicine student Puneeth Guruprasad and postdoc Shan Liu suggests that a component of the keto diet could boost CAR T cell therapy to help treat cancer.
FULL STORY →
Carl June: 2024 will be seen as a breakthrough year for brain cancer
Carl June of the Perelman School of Medicine shares five insights on using CAR T cell therapy to combat cancer, featuring remarks from Bruce Levine.
FULL STORY →
Penn plans to build a proton center for cancer treatment at Presbyterian Medical Center
Penn Medicine will build its fourth proton beam center for cancer treatment at Penn Presbyterian Medical Center in University City.
FULL STORY →
Double mastectomies do not improve breast cancer survival likelihood for most women, study finds
Angela DeMichele of the Perelman School of Medicine says that chemotherapy and hormonal therapies are important for combating breast cancer because they’re designed to kill spreading cells.
FULL STORY →
Breast cancer survival not boosted by double mastectomy, study says
Angela DeMichele of the Perelman School of Medicine comments on a study which found that breast cancer survival is not boosted by a double mastectomy.
FULL STORY →
How did Shannen Doherty die? What to know about ‘90210’ star’s cause of death
According to Penn Medicine, there is no known cure for metastatic breast cancer.
FULL STORY →